David Colleran insider trades
Open-market stock purchases and sales by David Colleran, EVP, General Counsel, Corp Sec at Anika Therapeutics, Inc, from SEC Form 4 filings since Feb 24, 2016.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 15, 2026 | ANIK Anika Therapeutics, Inc | Bought (not open market) | — |
| Mar 15, 2026 | ANIK Anika Therapeutics, Inc | Sold (not open market) | $26.9K |
| Mar 14, 2026 | ANIK Anika Therapeutics, Inc | Bought (not open market) | — |
| Mar 14, 2026 | ANIK Anika Therapeutics, Inc | Sold (not open market) | $59.2K |
| Mar 14, 2026 | ANIK Anika Therapeutics, Inc | Bought (not open market) | — |
| Mar 9, 2026 | ANIK Anika Therapeutics, Inc | Sold (not open market) | $28.7K |
| Mar 9, 2026 | ANIK Anika Therapeutics, Inc | Bought (not open market) | — |